Dr. Quan Zhou is an Instructor in the Department of Neurosurgery and the Molecular Imaging Program at Stanford (MIPS). She also serves as the co-lead for the MIPS Trainees Council. Currently, she leads a Phase I/II clinical trial on molecular-targeted fluorescence-guided neurosurgery, which is designed to increase the accuracy of brain malignancy resections. She has also developed a molecule-targeted clinical theranostic imaging framework. This framework uses clinical, radiographic, and tumor microenvironment features to predict how therapies will distribute within brain tumors. Another area of her research involves the molecular imaging of intratumoral immunosuppression in high-grade gliomas and methods to improve antibody delivery through the blood-brain barrier.
Dr. Zhou completed her PhD in biomedical engineering from the University of Michigan, Ann Arbor. During this period, she delved into peptide-based molecular imaging probes for cancer detection, earning the Research Foundation Award by the American Gastroenterological Association. Her recent work on the determinants affecting clinical imaging outcomes was recognized with the Alavi-Mandell Award from the Society of Nuclear Medicine and Molecular Imaging. Furthermore, she is the Principal Investigator for a Pilot Grant awarded by the Maternal and Child Health Research Institute.
In addition to her academic and research endeavors, Dr. Zhou is part of the fundraising committee for the Women in Molecular Imaging Network (WIMIN). The World Molecular Imaging Society acknowledged her contributions to the molecular imaging field with the WIMIN Rising Star Award. In her free time, she enjoys reading, stand-up comedy, and long walks.
